The Paclitaxel In-Stent Controlled Elution Study (PISCES) is a nonrandomized, dose-ranging registry trial in patients with single de novo lesions that evaluated the Conor (Conor MedSystems, Inc., ...
Results from the PANDA III Study Reported at TCT 2015 SAN FRANCISCO – October 14, 2015 – Results from the multicenter, prospective, randomized PANDA III trial indicate that the BuMA sirolimus-eluting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback